Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland

In this study, we report the emergence ofFKS-mutantCandida albicans/glabrata in Switzerland and provide the microbiological and clinical characteristics of 9 candidemic episodes. All patients were previously exposed to echinocandins (median 26  days; range 15–77). Five patients received initial echinocandin therapy with persistent candidemia in 4 of them. Overall mortality was 33%.
Source: Infection - Category: Infectious Diseases Source Type: research